The medicinal activity of lyophilized aqueous seed extract of Lepidium sativum L. in an androgenic alopecia model

Sci Rep. 2023 May 11;13(1):7676. doi: 10.1038/s41598-023-33988-1.

Abstract

This study evaluated the topical effect of Lepidium sativum lyophilized seed extract (LSLE) towards Sustanon-induced alopecia in male adult Wistar albino rats in vivo, compared to minoxidil topical reference standard drug (MRD). LC-MS/MS together with molecular networking was used to profile the metabolites of LSLE. LSLE treated group revealed significant changes in alopecia related biomarkers, perturbation of androgenic markers; decline in testosterone level and elevation in 5α-reductase (5-AR); decline in the cholesterol level. On the other hand, LSLE treated group showed improvement in vascular markers; CTGF, FGF and VEGF. Groups treated topically with minoxidil and LSLE showed significant improvement in hair length. LC-MS/MS profile of LSLE tentatively identified 17 constituents: mainly glucosinolates, flavonoid glycosides, alkaloids and phenolic acids. The results point to the potential role of LSLE in the treatment of alopecia through decreasing 5(alpha)-dihydrotestosterone levels. Molecular docking was attempted to evaluate the probable binding mode of identified compounds to androgen receptor (PDB code: 4K7A).

MeSH terms

  • 5-alpha Reductase Inhibitors / pharmacology
  • Alopecia / drug therapy
  • Animals
  • Chromatography, Liquid
  • Hair*
  • Lepidium sativum
  • Minoxidil* / pharmacology
  • Molecular Docking Simulation
  • Plant Extracts / therapeutic use
  • Rats
  • Tandem Mass Spectrometry

Substances

  • 5-alpha Reductase Inhibitors
  • Minoxidil
  • Plant Extracts